Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-12

FDA Approved: ELIMITE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for ELIMITE (permethrin) submitted by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ELIMITE (PERMETHRIN)

Snippet

SUPPL AP for ELIMITE (PERMETHRIN)